414 related articles for article (PubMed ID: 17963108)
1. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
Zhang JZ; Xi X; Gao L; Kern TS
Curr Eye Res; 2007 Oct; 32(10):883-9. PubMed ID: 17963108
[TBL] [Abstract][Full Text] [Related]
2. Role of angiotensin II in retinal leukostasis in the diabetic rat.
Chen P; Scicli GM; Guo M; Fenstermacher JD; Dahl D; Edwards PA; Scicli AG
Exp Eye Res; 2006 Nov; 83(5):1041-51. PubMed ID: 16822509
[TBL] [Abstract][Full Text] [Related]
3. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Ottlecz A; Bensaoula T
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
Zheng Z; Chen H; Xu X; Li C; Gu Q
Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
[TBL] [Abstract][Full Text] [Related]
6. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.
Ebrahimian TG; Tamarat R; Clergue M; Duriez M; Levy BI; Silvestre JS
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):65-70. PubMed ID: 15528473
[TBL] [Abstract][Full Text] [Related]
7. Captopril inhibits glucose accumulation in retinal cells in diabetes.
Zhang JZ; Gao L; Widness M; Xi X; Kern TS
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):4001-5. PubMed ID: 12939321
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin system and the developing retinal vasculature.
Sarlos S; Wilkinson-Berka JL
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1069-77. PubMed ID: 15728567
[TBL] [Abstract][Full Text] [Related]
9. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
10. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS
Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377
[TBL] [Abstract][Full Text] [Related]
11. [The experimental study of captopril and valsartan on the preventing and treatment of diabetic retinopathy in diabetic mice].
Xie XW; Zhao P
Zhonghua Yan Ke Za Zhi; 2004 Nov; 40(11):770-3. PubMed ID: 15634486
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
Agardh E; Hultberg B; Agardh C
Curr Eye Res; 2000 Jul; 21(1):543-9. PubMed ID: 11035534
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
14. Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat.
Hammes HP; Klinzing I; Wiegand S; Bretzel RG; Cohen AM; Federlin K
Invest Ophthalmol Vis Sci; 1993 May; 34(6):2092-6. PubMed ID: 8491559
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.
Kowluru RA; Odenbach S
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4161-6. PubMed ID: 15505070
[TBL] [Abstract][Full Text] [Related]
16. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
17. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
Gilbert RE; Kelly DJ; Cox AJ; Wilkinson-Berka JL; Rumble JR; Osicka T; Panagiotopoulos S; Lee V; Hendrich EC; Jerums G; Cooper ME
Diabetologia; 2000 Nov; 43(11):1360-7. PubMed ID: 11126403
[TBL] [Abstract][Full Text] [Related]
19. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
Padilla E; Ganado P; Sanz M; Zeini M; Ruiz E; Triviño A; Ramírez AI; Salazar JJ; Ramírez JM; Rojas B; Hoz Rd; Tejerina T
Diabetes Metab Res Rev; 2005; 21(2):132-42. PubMed ID: 15386814
[TBL] [Abstract][Full Text] [Related]
20. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S
Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]